EUVIMEDTutustu EUVIMEDiin
Open access

An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade

Angelo Corti, Anna Maria Gasparri, Barbara Colombo, Giulia Taiè, Elisa Sangiovanni, Leopoldo Sitia, Valeria Barreca, Alice Schirru, Alessandro Gori, Luc Garrigues, Sophie Chabot, Annapaola Andolfo and 5 more

Theranostics · 2026-07-29 · 16 (15) · 8478-8500

DOI: 10.7150/thno.131237 ↗

At a glance

Journal article in Theranostics, published on 2026-07-29. Written by Angelo Corti and 16 co-authors. Institution: Tumor Biology and Vascular Targeting Unit, Comprehensive Cancer Center, IRCCS San Raffaele Scientific Institute, Milan, Italy. Major MEDLINE topics: Integrins, Antigens, Neoplasm, Transforming Growth Factor beta, Immune Checkpoint Inhibitors. The full text is freely available in PubMed Central.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Tiivistelmää ei ole saatavilla.

Subjects

MeSH terms (MEDLINE)

IntegrinsAntigens, NeoplasmTransforming Growth Factor betaImmune Checkpoint InhibitorsAnimalsHumansMiceCell Line, TumorFemaleAntineoplastic Agents

Author keywords

TGFβcancerchromogranin Apeptibodyαvβ6 and αvβ8 integrins

Substances

integrin alphavbeta6IntegrinsAntigens, NeoplasmTransforming Growth Factor betaintegrin alphavbeta8Immune Checkpoint InhibitorsAntineoplastic Agents

Authors and institutions

  • Tumor Biology and Vascular Targeting Unit, Comprehensive Cancer Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy.
  • Lymphocyte Activation Unit, Division of Immunology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Istituto di Scienze e Tecnologie Chimiche (SCITEC-CNR), National Research Council of Italy, Milan, Italy.
  • Translational Biology, In vivo Pharmacology and Analytical Chemistry, Evotec, 195, Route D'Espagne, 31100, Toulouse, France.
  • Proteomics and Metabolomics Facility, Center for Omics Sciences, IRCCS San Raffaele, Milan, Italy.

Cite

APA

Corti, A., Gasparri, A. M., Colombo, B., Taiè, G., Sangiovanni, E., Sitia, L., Barreca, V., Schirru, A., Gori, A., Garrigues, L., Chabot, S., Andolfo, A., Ponzoni, M., Mondino, A., Pocaterra, A., Doglioni, C., & Curnis, F. (2026). An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade. Theranostics, 16(15), 8478-8500. https://doi.org/10.7150/thno.131237

Vancouver

Corti A, Gasparri AM, Colombo B, Taiè G, Sangiovanni E, Sitia L, et al. An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade. Theranostics. 2026;16(15):8478-8500. doi:10.7150/thno.131237

BibTeX
@article{Corti2026,
  author = {Corti, Angelo and Gasparri, Anna Maria and Colombo, Barbara and Taiè, Giulia and Sangiovanni, Elisa and Sitia, Leopoldo and Barreca, Valeria and Schirru, Alice and Gori, Alessandro and Garrigues, Luc and Chabot, Sophie and Andolfo, Annapaola and Ponzoni, Maurilio and Mondino, Anna and Pocaterra, Arianna and Doglioni, Claudio and Curnis, Flavio},
  title = {An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade},
  journal = {Theranostics},
  year = {2026},
  volume = {16},
  number = {15},
  pages = {8478--8500},
  doi = {10.7150/thno.131237}
}
Start for free →